IPO Trending
GLANDSME / NSE, BSEListed

Gland Pharma Limited

Founded in Hyderabad, India, in 1978, Gland Pharma has evolved from a small-scale contract manufacturer to one of the largest and fastest-growing injectable-focused companies. It has a global presence in 60 countries, including the United States, Europe, Canada, Australia, and India. Operating primarily under a B2B model, Gland Pharma has a strong track record in developing, manufacturing, and marketing complex injectables. Its integrated presence across the value chain has fueled rapid growth. The company is promoted by Shanghai Fosun Pharma, a leading global pharmaceutical company.

₹1,490 - ₹1,500Open
Listed Price1710.00
Listing Gain+14.00%
Subscription0x total demandUpdated 22 Dec 2025, 08:29 AM
Subscription PendingExchange subscription breakup is not available yet.

Category-wise demand has not been published yet. Check back after the exchange updates the live subscription feed.

Open Date09 Nov 2020
Close Date11 Nov 2020
Listing Date20 Nov 2020